Blue Edge Capital, LLC - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.

Quarter-by-quarter ownership
Blue Edge Capital, LLC ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q4 2021$2,662,718,000
+1.6%
83,132
-6.5%
0.51%
-6.0%
Q3 2021$2,620,797,000
-13.3%
88,931
-0.0%
0.55%
-12.8%
Q2 2021$3,023,099,000
+126.9%
88,967
+117.0%
0.63%
+111.8%
Q1 2021$1,332,467,000
-9.1%
40,999
+0.8%
0.30%
-16.4%
Q4 2020$1,465,294,000
-5.7%
40,680
+2.5%
0.35%
-16.3%
Q3 2020$1,554,495,00039,6960.42%
Other shareholders
VANECK VECTORS ETF TR shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders